TALL CLAIMS
A lawsuit filed in the US district court in San Francisco has accused three pharmaceutical firms -Boots Co of UK, BASF AG of Germany and its US subsidiary Knoll Pharmaceuticals -of covering up a report questioning the effectiveness of a thyroid drug. The lawsuit alleges that the drug companies concealed a seven-year-long study that concluded that their thyroid drug, Synthroid, was no better than cheaper generic brands at treating people suffering from hypothyroidism, a condition caused by an underactive thyroid gland. Martin Wakeling, a Boots spokes- person, dismissed the allegations as "totally fanciful".
Related Content
- Parties’ tall claims for rejuvenation of lakes
- 2,754 Gujarat villages have no grazing land, government admits
- 6 cases of dengue, 2 of swine flu reported
- Fogging drive running behind schedule
- Govt claim on visible progress false: IISc team
- Questioning the “phenomenal success” of Aadhaar-linked Direct Benefit Transfers for LPG